10-Q/A XBRL

FORM 10-Q/A

Company: GT Biopharma, Inc.
Filed: February 28, 2018
Period of Report: September 30, 2016
Accession Number: 0001654954-18-001972

View Document ↗ View on SEC.gov ↗